Psoriatic Arthritis

Psoriatic Arthritis, Cardiovascular Health Improved With Etanercept Therapy

Psoriatic Arthritis, Cardiovascular Health Improved With Etanercept Therapy

By

The researchers noted that the small changes in lipid profile do not account for the cardiovascular benefits seen in patients taking etanercept.

Early Predictors of Poor Long-Term Treatment Response in Spondyloarthritis

Early Predictors of Poor Long-Term Treatment Response in Spondyloarthritis

By

Determining which patients are unlikely to respond to therapy early on may help reduce unnecessary treatment and contain costs.

Tofacitinib Found to Improve Nail Psoriasis

Tofacitinib Found to Improve Nail Psoriasis

There was improvement in nail psoriasis severity at 16 weeks compared with placebo that was maintained through 52 weeks.

Serum Amyloid A Levels May Act as Biomarker for Disease Activity in Psoriatic Arthritis

Serum Amyloid A Levels May Act as Biomarker for Disease Activity in Psoriatic Arthritis

By

Repeated serum amyloid A measurements could act as an additional marker for monitoring disease activity over time in patients with psoriatic arthritis.

No Negative Effect on Disease Activity Seen in Switching Patients to Biosimilar Infliximab From Originator Drug

No Negative Effect on Disease Activity Seen in Switching Patients to Biosimilar Infliximab From Originator Drug

By

Researchers found similar disease duration the 3 months before and after the switch to CT-P13 in patients.

Ixekizumab Benefits Patients With Treatment-Resistant Psoriatic Arthritis

Ixekizumab Benefits Patients With Treatment-Resistant Psoriatic Arthritis

By

Ixekizumab was found to benefit patients with psoriatic arthritis showing poor response to conventional treatment when administered over a 2- or 4-week period.

Risk for Endocrine Comorbidities Increased in Psoriatic Arthritis

Risk for Endocrine Comorbidities Increased in Psoriatic Arthritis

By

Researchers evaluated the prevalence of several endocrine disorders in patients with psoriatic arthritis.

GRAPPA-OMERACT: PsA Outcomes Measures Updated for Greater Inclusion of Patient Concerns

GRAPPA-OMERACT: PsA Outcomes Measures Updated for Greater Inclusion of Patient Concerns

By

The domains for outcome measurement in clinical trials of psoriatic arthritis were updated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis and endorsed by Outcome Measures in Rheumatology.

GRAPPA-OMERACT: Updated PsA Outcomes Measures Offer Greater Inclusion of Patient Concerns

GRAPPA-OMERACT: Updated PsA Outcomes Measures Offer Greater Inclusion of Patient Concerns

By

The domains for outcome measurement in clinical trials of psoriatic arthritis were updated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis and endorsed by Outcome Measures in Rheumatology.

Uveitis Risk Higher Among Patients With Psoriasis

Uveitis Risk Higher Among Patients With Psoriasis

By

Patients with severe psoriasis and those with mild psoriasis and concomitant psoriatic arthritis have an increased risk of uveitis.

First Line Biologic for Psoriasis Influenced By Certain Factors

First Line Biologic for Psoriasis Influenced By Certain Factors

By

Psoriatic arthritis, patient weight, registration country and more influence first-line biologic treatment selection for patients with psoriasis.

Biosimilar Confidence: Physician-Patient Communication Sets the Tone

Biosimilar Confidence: Physician-Patient Communication Sets the Tone

By

Jonathan Krant, MD, FACP, confronts the issues surrounding biosimilar substitution for biologic treatments.

Measuring Disease Activity in Psoriatic Arthritis

Measuring Disease Activity in Psoriatic Arthritis

By

There are many tools to evaluate disease activity in psoriatic arthritis, but there is no consensus on which one to use.

Women Have Lower Psoriasis Area and Severity Index Scores Than Men

Women Have Lower Psoriasis Area and Severity Index Scores Than Men

By

Women were found to have a lower median of scores in the Psoriasis Area and Severity Index than men.

Psoriatic Arthritis Development Predicted by Musculoskeletal Symptoms

Psoriatic Arthritis Development Predicted by Musculoskeletal Symptoms

By

Prospective cohort study of patients with psoriasis who were assessed annually to examine for development of clinical psoriatic arthritis.

High-dose Steroids Increase Serious Infection Risk in Pregnant Women With Inflammatory Conditions

High-dose Steroids Increase Serious Infection Risk in Pregnant Women With Inflammatory Conditions

By

An observational cohort study of 4961 women with completed pregnancies and a recorded diagnosis of systemic inflammatory conditions.

Minimal Amount of TNF Inhibitor Transfers to Breast Milk, Study Finds

Minimal Amount of TNF Inhibitor Transfers to Breast Milk, Study Finds

By

Study evaluated breast milk samples from 17 lactating mothers diagnosed with rheumatoid arthritis, Crohn's disease, psoriatic arthritis, and axial spondyloarthritis/ankylosing spondylitis.

Secukinumab Efficacy for Psoriasis Examined After Treatment Pause

Secukinumab Efficacy for Psoriasis Examined After Treatment Pause

By

Findings come from 2 trials; one compared secukinumab with placebo, whereas the other compared secukinumab with placebo and etanercept.

Arthritis and Incident Myocardial Infarction Risk

Arthritis and Incident Myocardial Infarction Risk

By

Research comes from meta-analysis of 25 population-based studies on 5 major forms of arthritis.

Depression Significantly Increases Psoriatic Arthritis Risk Among Patients With Psoriasis

Depression Significantly Increases Psoriatic Arthritis Risk Among Patients With Psoriasis

By

Study evaluated clinical data to determine a possible role of major depressive disorders in the progression of inflammatory disease.

FDA Approves Brodalumab Injection for Plaque Psoriasis Treatment

FDA Approves Brodalumab Injection for Plaque Psoriasis Treatment

By

Siliq will carry a Black Box Warning and is available only through a restricted program.

The Handoff: Your Week in Rheumatology News - 2/17/17

The Handoff: Your Week in Rheumatology News - 2/17/17

By

Clinical management recommendations for juvenile dermatomyositis, updated guidelines for low back pain treatment, and more of this week's news.

Chronic Plaque Psoriasis Leads to Higher Fatigue Levels

Chronic Plaque Psoriasis Leads to Higher Fatigue Levels

By

Study evaluated prevalence and severity of fatigue among patients with chronic plaque psoriasis and healthy controls.

Psoriasis Treatment Negatively Impacted By Interrupted Ixekizumab Therapy

Psoriasis Treatment Negatively Impacted By Interrupted Ixekizumab Therapy

By

Most patients with psoriasis who were withdrawn from ixekizumab therapy experienced disease relapse.

Psoriatic Arthritis Strongly Linked With Developing Diabetes Mellitus

Psoriatic Arthritis Strongly Linked With Developing Diabetes Mellitus

By

Researchers find that higher levels of disease activity predict the development of diabetes mellitus in patients with psoriatic arthritis.

Urinary Proteomic Biomarkers May Help Differentiate Inflammatory Arthritis

Urinary Proteomic Biomarkers May Help Differentiate Inflammatory Arthritis

By

Researchers look for diagnostic alternative to blood samples for diagnosing specific inflammatory arthritis conditions.

Does Psoriatic Arthritis and Psoriasis Increase Risk of Fracture Development?

Does Psoriatic Arthritis and Psoriasis Increase Risk of Fracture Development?

By

A population-based cohort study compared patients with psoriatic arthritis, psoriasis, and rheumatoid arthritis with matched comparators to determine fracture risk associated with the conditions.

Childhood Psoriasis Also Impacts Parents' Quality of Life

Childhood Psoriasis Also Impacts Parents' Quality of Life

By

Emotional well-being negatively impacted among parents with affected children.

Increased Prevalence of Coronary Atherosclerosis in Psoriatic Arthritis

Increased Prevalence of Coronary Atherosclerosis in Psoriatic Arthritis

By

The prevalence and severity of coronary atherosclerosis, measured by coronary CT angiography, were compared in patients with psoriatic arthritis and age/gender-matched controls.

Psoriasis Symptoms Reduced With Long-Term Weight Loss

Psoriasis Symptoms Reduced With Long-Term Weight Loss

Obese patients with psoriasis experience quality-of-life improvement after losing significant amounts of weight.

Sign Up for Free e-newsletters